t (b+f)/f b/f 0.8 1.8 3.4 ‘late’ or ‘early’ image? whose brain is this? why a ct scan first?...

7
t (B+F)/F B/F 0.8 1.8 3.4 ‘late’ or ‘early’ image? whose brain is this? why a CT scan first? why increasing contrast w/ time? why increasing noise w/time? what is the point of excess cold spiperone? what do we learn from it re the caudate? can we compare these numbers across scans? why divide by cerebellum value? could we do this exp’t in a human?

Post on 19-Dec-2015

215 views

Category:

Documents


1 download

TRANSCRIPT

t (B+F)/F B/F

0.81.83.4

‘late’ or ‘early’ image?

whose brain is this?

why a CT scan first?

why increasing contrast w/ time?

why increasing noise w/time?

what is the point of excess cold spiperone?

what do we learn from it re the caudate?

can we compare these numbers across scans?

why divide by cerebellum value?

could we do this exp’t in a human?

•where do error bars come from?•(if so) is the Y axis correct?•where does “specific putamen” come from – special brain area known only in Sweden?

•what is plotted? (B vs F) – how did they get these values?•how did they get 5 data points•what is the slope near origin?•what is the assymptotic value for Y axis?

where does “expected spec binding” come from?

Is this a safe comparison? what factors are ignored?

understand this?got equilibrium?

raclo in cereb (assume = free) --> plug into Bmax*Free/[Kd + Free] using Bmax and Kd from Healthy controls --> predicts B at equilib for schizo patients. Compare to actual B measured for patients (via [striat-cereb] per injected dose – I hope)

first ‘drug occupancy’ study with PET?

receptor occup = B/B (fractional change in binding due to presence of bound drug) = (Bpredicted – Bactual)/Bpredicted

claim: uniformity of occupancy of D2 by different drugs suggests that occupancy level is related to efficacy.

P F B

typically written as…

what’s all this about?

what is ?

conservation of mass

under what condition?what is the blue? what is the fraction of P that is blue – according to Mintun? according to us?

Mintun: can’t estimate

Bmax and rate constants

from high spec act

expm’t

parameter estimation – what is it? why is it iterative?

simulations? what are they good for? what are they used for here?

sensitivity analysis – huh?

kon*Bmax = Bmax

koff KD

BP is an equilibrium ratio (has not units of time or rates) but we can get it from a TRANSIENT experiment.

anything tricky about using an in vitro sample for anatomy?

what’s the difference between expt 1 and expt 2 in same baboon?

why didn’t they estimate BP in 2nd study?

terms for next week: Sept 21

displacement

release

endogenous

simulation

what is Logan proving by her simulations? where they get their parameter vals

what things might be causing DA release in Koepp expt? what might have been a better control condition(s)? what do (+) changes in binding potential (Fig 2) mean?

what is the ‘proof’ that DA release is being measured?

what is being optimized in Morris paper? where do they get their parameter vals?